Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Theravance Biopharma Inc
Swot
Theravance Biopharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Theravance Biopharma Inc has 10 Strengths, 9 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(9)
Opportunity
(0)
Threats
(3)
Others
(2)
Price crossing above SMA20 today, and greater than SMA5
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Week
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Momentum Trap (DVM)
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
